Patient’s Care and Nursery in Modern Medicine

Da-Yong Lu1*, Yu-Zheng Chen2, Da-Feng Lu2, Jin-Yu Che1

1 Shanghai University, Shanghai, People’s Republic of China, China
2 The Second Hospital of Neijiang District,  Sichuan Province, People’s Republic of China, China

CitationCitation COPIED

Lu DY, Chen YZ, Lu DF, Che JY. Patient’s care and nursery in modern medicine. Nurs Pract Health Care. 2019 Feb;1(1):101

© 2019 Lu DY, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 international License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.


A great proportion of healthcare efforts is a modern challenge. The promotion of the quality and diversity of medical nursing is as important as doctorial areas for patient’s recovery and survivals until now. Nursing activity may be expected with growing academic notification and respect (economic and career benefits) globally. This editorial addresses parts of these medical challenges and highlights their possible trends in the future.


Healthcare; Nursing; Medical service; Modern technology; Mathematicians; Psychoanalysis



Today, a half of major diseases are chronic diseases. Their recovery processes are not defined in operation-room (surgery), but getting better in the bedside (therapeutic conventions-drugs, nutrition and instruments) -including nursery process (physical or spiritual assistance). A great proportion of healthcare efforts for a chronic or dying patient in a general hospital are both doctors and nursing [1-6]. Any unilateral activity may lead to therapeutic compromise.

Major Efforts and Categories

Medical care and nursing play critical roles on patient’s recovery and disease controls. The promotion of the quality and scope of medical healthcare and nursing activity is as important as doctorial efforts until now. However, currently, nursing activities in hospitals does not receive enough academic notification and economic respects globally. This editorial addresses parts of these medical challenges and highlights into new trends.

Major Disease and Relevant Nursery

There is no nursery knowledge that can be applied on every medical discipline. In the past educational system, nursery education was regarded as uniformity. Nursery work is commonly considered as sub-ordinary and less important. In this stereotypic mindset, nurse may be placed everywhere. This leads to slow progress of nursery science discovery and developments (Table 1).

Current Scenarios

Current norm of patient’s care and nursing are provided by doctors and facility of different hospitals. Little attention is given to many specific or individualized patients. System developments for these services are neglected in most hospitals. This difference requires efforts from both doctors and patients. Hospitals provide nursery services according to their own mindset. Some patients who have some peculiar custom may greatly affect by uniform nursery systems. In our opinion, medical care and nursing should be targeted to every patient. Individualized nursing should be established in the future.

Table 1: A general picture of nursery services for major diseases

Central Topics

Salary promotion

Entering into this millennium, technical and education for nurses increase dramatically. However, the income of these healthcare service (nursery items) increases slowly. Loss of motivation and commitments from experienced nurses and talents are common phenomenon. The nurse’s physical requirement is no less than many types of doctors. Adequate economic increase of healthcare providers and nurses is important and indispensable. Cost balance between doctors’ diagnosis/prescription and patients’ nursing activity will be a future challenge.

Grading technical position

Grading for nurse’s activity and technical positions in hospitals may be an effective policy for keeping up the quality of patient’s care and getting back of health care talents. Most doctors are commonly too busy to take care of patients in each detail and regulatory monitor. We must respect the nurses and assistant work. Without nursery services, maximizing patient’s care will be an un-attainable goal.

Future Directions
 Teamwork in modern medicine

Therapeutics in the future is no longer a performance and decision-making by doctors alone [7,8]. Many technical or assistance forces will take part of medical practice for quality boosting including pharmacologists, pathologists, biochemical technologists, nurses, mathematicians and many others. Without the assistance of these experts, clinical doctors will be narrow-minded and difficult to execute best therapeutics for all patients. This modern trend is unavoidable and eventually improving globally

In summary, different types of nursery play key roles in clinical trials, especially chronic diseases, such as HIV/AIDS treatments [9], mental diseases [10-13], bone disorders [14-17], metabolic diseases [18-23], cancers [24-25] and so on.


Patient’s care and nursery play important roles for patient treatments and recovery. In order to promote these kinds of medical and technical work, new policy and creative ideas must be implemented in the future. To conclude, we must respect these kinds of medical services and promote them into new levels.


1. Ahmad S. An Old Disease, A New Insights. Springer Science. (Ref)

2. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes; a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2:56-64. (Ref)

3. Grimaccia F, Kanavos P. Cost, outcomes, treatment pathways and challenges for diabetes care in Italy. Global Health. 2014 Jul;10:58. (Ref)

4. Da Lu. Personalized cancer chemotherapy, an effective way for enhancing outcomes in clinics. Woodhead Publishing, Elsevier. 2014. (Ref)

5. Lu DY. Suicide Risks and Treatments, New Ideas and Future Perspectives. Nova Science Publishers. 2017;New York, USA. (Ref)

6. Lu DY. HIV/AIDS Treatments, Fight for a Cure. LAMBERT Academic Publishing. 2017, Germany. 

7. Lu DY, Zhu PP, Lu TR, Che JY. The suicidal risks and treatments, seek medications from multi-disciplinary. Cent Nerv Syst Agents Med Chem. 2016;16(3):231-239. (Ref)

8. Lu DY, Zhu PP, Wu HY, Lu Y, Che JY. New modes of suicide/ mental disorder diagnostics and therapeutics. Suicide Risks and Treatments, New Ideas and Future Perspectives. Nova Science Publishers. 2017, New York, USA. 

9. Lu DY, Wu HY, Yarla NS, Xu B, Ding J, et al. HAART in HIV/AIDS treatments, future trends. Infectious Disorders-Drug Targets. 2018;18(1):15-22. (Ref)

10. Serafini G, Salano P, Amore M. Suicidal ideation: a comprehensive overview. Suicidal Ideation: Predictors, Prevalence and Prevention. Nova Science Publishing. 2015, USA. 

11. While D, Bickley H, Roscoe A, Windfuhr K, Rahman S, et al. Implementation of mental health service recommendations in England and Wales and suicide rates, 1997-2006: a cross-sectional and before-and-after observational study. Lancet. 2012;379:1005-1012. 

12. Lu DY, Lu TR, Lu Y, Cao S. Introduction for suicide study. Journal Metabolic Syndrome. 2017;6(2):227. 

13. Lu DY, Zhu PP, Wu HY, Yarla NS, Xu B, et al. Human suicide risk and treatment study. Cent Nerv Syst Agents Med Chem. 2018;18(3):206-212. 

14. Melton J. Hip fracture; a worldwide problem today and tomorrow. Bone. 1993;14:S1-S8. (Ref)

15. Silva DMW. Diagnosis of osteoporosis; bone mineral density, risk factors, or both. EC Orthopaedics. 2018;9(7):500-502. 

16. Lu DY, Che JY, Shen Y. Osteoporosis in old women, therapeutic selection. EC Orthopaedics. 2018;9(7):386. (Ref)

17. Lu DY, Che JY, Shen Y. Clinical treatments of osteoporosis, how to target co-morbidities. EC Orthopaedics. 2018;9(11):781-782. (Ref)

18. Putta S, Peluso I, Yarla NS, Kilari EK, Bishayee A, et al. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications. Curr Pharm Des. 2017;23(30):4475-4483. (Ref)

19. Lu DY, Che JY, Yarla NS, Zhu H, Lu TR, et al. Type 2 diabetes study, introduction and perspective. The Open Diabetes Journal. 2018;8:13-21. (Ref)

20. Lu DY, Che JY, Yarla NS, Wu HY, Lu TR, et al. Type 2 diabetes treatment and drug development study. The Open Diabetes J. 2018;8:22-33. (Ref)

21. Lu DY, Che JY, Lu Y, Yarla NS, Xu B, et al. An overview of obesity. Metabolomics. 2018;8(2):200. (Ref)

22. Lu DY, Che JY, Wu HY, Yarla NS, Xu B, et al. Obesity, risks and managements. Metabolomics. 2018;8(1):e156. (Ref)

23. Lu DY, Che JY, Lu TR, Lu Y, Huang YK, et al. Pathology and treatments of obesity. Trends in Medicine. 2018;8(5):157. 

24. Lu DY, Lu TR, Xu B, Ding J, Lu Yi, et al. Perspectives of personalized cancer therapy. Adv Biotechnology & Microbiology. 2017;4(3):555637. (Ref)

25. Lu DY, Lu TR, Che JY, Shen Y, Yarla NS. Individualized cancer therapy, future approaches. Current Pharmacogenomics & Personalized Medicine. 2018;16(2):156-163. (Ref)